Metraipolis › archive › dc_117f94ff910d
Cost-Effectiveness of Blood-Based Fibrosis Screening in High-Risk Metabolic Liver Diseases With Emerging Therapies — Europe PMC PMID:42006195
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42006195
- DOI
- 10.1016/j.gastha.2026.100923
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-04T20:33:31.404Z
- SHA-256 of the archived text
21570a3601a754b51a269cda11f17f63565c310064c0736c821a4d6d9fd9bd08- Stable URL of this page
https://metraipolis.com/documento/dc_117f94ff910d
How to cite
Cost-Effectiveness of Blood-Based Fibrosis Screening in High-Risk Metabolic Liver Diseases With Emerging Therapies — Europe PMC PMID:42006195 — Europe PMC (en), https://europepmc.org/article/MED/42006195 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_117f94ff910d (Metraipolis archive dc_117f94ff910d, sha256 21570a3601a754b51a269cda11f17f63565c310064c0736c821a4d6d9fd9bd08)
BibTeX
@misc{dc117f94ff910d,
title = {Cost-Effectiveness of Blood-Based Fibrosis Screening in High-Risk Metabolic Liver Diseases With Emerging Therapies — Europe PMC PMID:42006195},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42006195},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_117f94ff910d; sha256 21570a3601a754b51a269cda11f17f63565c310064c0736c821a4d6d9fd9bd08},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42006195. Agents can read the archived copy with the MCP tool read_document.